# Axcelis Technologies Inc: Form 10-Q for the period ended Sep 30, 2010

- Company: [Axcelis Technologies Inc](/companies/acls.md) (CIK 1113232)
- Form: 10-Q
- Filed: 2010-11-05
- Accepted by EDGAR: Nov 5, 2010, 16:47 ET
- Period: 2010-09-30
- Accession: 0001104659-10-056579
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1113232/000110465910056579/a10-17336_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1113232/000110465910056579/

## Management's discussion and analysis

As filed, 22,487 characters.

Certain statements in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Form 10-Q are forward-looking statements that involve risks and uncertainties. Words such as may, will, should, would, anticipates, expects, intends, plans, believes, seeks, estimates and similar expressions identify such forward-looking statements. The forward-looking statements contained herein are based on current expectations and entail various risks and uncertainties that could cause actual results to differ materially from those expressed in such forward-looking statements. Factors that might cause such a difference include, among other things, those set forth under “Liquidity and Capital Resources,” and “Risk Factors” and others discussed elsewhere in this Form 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. We assume no obligation to update these forward-looking statements to reflect actual results or changes in factors or assumptions affecting forward-looking statements, except as may be required by law.

### Overview

The semiconductor capital equipment industry is subject to significant cyclical swings in capital spending by semiconductor manufacturers. Capital spending is influenced by demand for semiconductors and the products using them, the utilization rate and capacity of existing semiconductor manufacturing facilities and changes in semiconductor technology, all of which are outside of our control. As a result, our revenue and gross margins fluctuate from year to year and period to period. The industry experienced a downturn beginning in the second half of 2008 which extended through 2009, although signs of improvement began during the fourth quarter of 2009 and have continued through the first nine months of 2010. Our gross margins are also affected by the introduction of new products. We typically become more efficient in manufacturing products as they mature. Our expense base is largely fixed and does not vary significantly with changes in volume. Therefore, we experience fluctuations in operating results and cash flows depending on our revenue as driven by the level of capital expenditures by semiconductor manufacturers.

The sizable expense of building, upgrading or expanding a semiconductor fabrication facility is increasingly causing semiconductor companies to contract with foundries to manufacture their semiconductors. In addition, consolidation and partnering within the semiconductor manufacturing industry is increasing. We expect these trends to continue to reduce the number of our potential customers. This growing concentration of Axcelis’ customers may increase pricing pressure as higher percentages of our total revenue are tied to the buying decisions of a particular customer or a small number of customers.

During the last six months of 2008 and through 2009 challenging market conditions severely limited our ability to increase sales and market share. During this period, adverse market conditions such as credit constriction, higher unemployment, lower corporate earnings, lower business investment and lower consumer spending severely impacted many technology manufacturers and significantly lowered the demand for our products. During the three and nine months ended September 30, 2010, the market for our products have steadily improved. We also estimate we are gaining market share with our single wafer ion implant systems for high current and high energy applications (the Optima HDx and Optima XEx), as customers are showing a higher acceptance of our technology. Our expense base is reduced from earlier periods due to cost reduction initiatives implemented in 2009 and 2008.

Operating results for the periods presented are not necessarily indicative of the results that may be expected for future interim periods or years as a whole.

### Critical Accounting Estimates

Management’s discussion and analysis of our financial condition and results of operations are based upon Axcelis’ consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to revenue recognition, income taxes, accounts receivable, inventory and warranty obligations. Management’s estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

There has been no material change in the nature of our critical accounting estimates and judgments as described in Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2009.

### Results of Operations

The following table sets forth our results of operations as a percentage of revenue for the periods indicated:

### Axcelis Technologies, Inc.

### Consolidated Statements of Operations

### Percentage of Revenue

### (Unaudited)

| Revenue | Three months ended September 30, 2010 | 2009 | Nine months ended September 30, 2010 | 2009 |
| --- | ---: | ---: | ---: | ---: |
| Product | 88.1% | 73.9% | 86.4% | 73.6% |
| Service | 11.9 | 26.1 | 13.6 | 26.0 |
| Royalties from SEN | 0.0 | 0.0 | 0.0 | 0.4 |
| Total revenue | 100.0 | 100.0 | 100.0 | 100.0 |
| Cost of revenue |  |  |  |  |
| Product | 63.7 | 61.9 | 61.5 | 66.4 |
| Service | 7.7 | 15.7 | 8.6 | 15.9 |
| Total cost of revenue | 71.4 | 77.6 | 70.1 | 82.3 |
| Gross profit | 28.6 | 22.4 | 29.9 | 17.7 |
| Operating expenses |  |  |  |  |
| Research and development | 13.2 | 21.8 | 15.6 | 26.4 |
| Sales and marketing | 9.5 | 16.3 | 11.2 | 20.0 |
| General and administrative | 10.5 | 22.5 | 12.7 | 28.7 |
| Restructuring charges | 0.0 | 1.2 | 0.0 | 5.9 |
| Total operating expenses | 33.2 | 61.8 | 39.5 | 81.0 |
| Loss from operations | (4.6) | (39.4) | (9.6) | (63.3) |
| Other income (expense) |  |  |  |  |
| Gain on sale of SEN | 0.0 | 0.0 | 0.0 | 1.1 |
| Equity loss of SEN | 0.0 | 0.0 | 0.0 | (3.4) |
| Interest income | 0.0 | 0.2 | 0.0 | 0.2 |
| Interest expense | 0.0 | 0.0 | 0.0 | (1.8) |
| Other, net | (2.6) | (4.8) | (1.1) | (3.4) |
| Total other income (expense) | (2.6) | (4.6) | (1.1) | (7.3) |
| Loss before income taxes | (7.2) | (44.0) | (10.7) | (70.6) |
| Income taxes | 1.2 | 1.3 | 1.3 | 0.9 |
| Net loss | (8.4)% | (45.3)% | (12.0)% | (71.5)% |

12

### Three and nine months ended September 30, 2010 in comparison to the three and nine months ended September 30, 2009

### Revenue

#### Product

Product revenue, which includes systems sales, sales of spare parts and product upgrades, was $66.2 million, or 88.1% of revenue, for the three months ended September 30, 2010, compared with $25.9 million, or 73.9% of revenue for the three months ended September 30, 2009. Product revenue was $157.1 million, or 86.4% of revenue for the nine months ended September 30, 2010, compared with $69.4 million, or 73.6% of revenue for the nine months ended September 30, 2009. System sales were $39.1 million, or 52.1% of revenue, for the three months ended September 30, 2010, compared with $10.1 million, or 28.8% of revenue, for the three months ended September 30, 2009. System sales were $77.3 million, or 42.5% of revenue, for the nine months ended September 30, 2010, compared with $26.7 million, or 28.3% of revenue, for the nine months ended September 30, 2009. The increase in product revenue in the three and nine month period ended September 30, 2010 is attributable to the strengthening of the semiconductor market and a related increase in capital spending by semiconductor manufacturers. In addition, we also believe we are gaining market share with our single wafer ion implant systems for high current and high energy applications (the Optima HDx and Optima XEx), as customers are showing a higher acceptance of our technology.

A portion of our revenue from system sales is deferred until installation and other services related to future deliverables are performed. The total amount of deferred revenue at September 30, 2010 and 2009 was $11.5 million and $10.8 million, respectively. The increase was mainly due to the increase in systems sales in 2010.

#### Service

Service revenue, which includes the labor component of maintenance and service contracts and fees for service hours provided by on-site service personnel, was $8.9 million, or 11.9% of revenue, for the three months ended September 30, 2010, compared with $9.1 million, or 26.1% of revenue, for the three months ended September 30, 2009. Service revenue was $24.7 million, or 13.6% of revenue for the nine months ended September 30, 2010, compared with $24.5 million, or 26.0% of revenue for the nine months ended September 30, 2009. Although service revenue should increase with the expansion of the installed base of systems, it can fluctuate from period to period based on capacity utilization at customers’ manufacturing facilities, which affects the need for equipment service. The slight increase during the nine months ended September 30, 2010 was due to an increase in fabrication utilization in the semiconductor industry.

#### Royalties

Royalties were previously earned under our prior license agreement with SEN. As a result of the sale of our investment in SEN, SEN has had no further royalty obligations since March 30, 2009.

#### Ion Implant

Included in total revenue of $75.1 million for the three month period ended September 30, 2010, is revenue from sales of ion implantation products and service of $64.2 million, or 85.5% of total revenue, compared with $28.1 million, or 80.2% of total revenue, for the three months ended September 30, 2009. Revenue from sales of ion implantation products and service accounted for $153.2 million, or 84.3% of revenue, for the nine months ended September 30, 2010, compared to $77.7 million, or 82.2% of revenue, in the nine months ended September 30, 2009. The dollar increase was due to the factors discussed above for product revenue.

#### Aftermarket

The Company’s product revenues include sales of spare parts and product upgrades as well as complete systems. We refer to the business of selling spare parts and product upgrades, combined with the sale of maintenance labor and service contracts and service hours, as the “aftermarket” business. Included in total revenue of $75.1 million is revenue from our aftermarket business of $36.0 million for the three months ended September 30, 2010, compared to $24.9 million for the three months ended September 30, 2009. The revenue from our aftermarket business was $104.5 million for the nine months ended September 30, 2010, compared to $67.2 million for the nine months ended September 30, 2009. Aftermarket revenue generally increases with expansion of the installed base of systems but can fluctuate period to period based on capacity utilization at customers’ manufacturing facilities, which affects the sale of spare parts and demand for equipment service.

### Gross Profit

#### Product

Gross profit from product revenue was 27.7% for the three months ended September 30, 2010, compared to gross profit of 16.2% for the three months ended September 30, 2009. Approximately 2.1% of the 11.5% increase resulted from a lower provision for excess inventory. The remaining 9.4% increase in gross profit from product revenues is attributable to higher systems sales volume and the related favorable absorption of fixed overhead costs, which increased gross margins by 20.1%, offset by a 10.7% decrease in gross margin resulting from an unfavorable mix of parts and upgrade revenue. Gross profit from product revenue was 28.8% for the nine months ended September 30, 2010, compared with 9.8% for the nine months ended September 30, 2009. Approximately 4.8% of the 19.0% increase resulted from a lower provision for excess inventory. The remaining 14.2% increase in gross profit from product revenue is attributable to the higher systems sales volume during the nine months ended September 30, 2010 and the related favorable absorption of manufacturing overhead which increased gross margins by 17.4%, offset by a 3.2% decrease in gross margin resulting from the unfavorable impact of a decreased mix of parts and upgrade revenue at higher margins.

#### Service

Gross profit from service revenue was 35.3% for the three months ended September 30, 2010, compared to 39.7% for the three months ended September 30, 2009. The decrease in gross profit is attributable to lower volumes. Gross profit from service revenue was 36.8% for the nine months ended September 30, 2010, compared to 38.8% for the nine months ended September 30, 2009. The decrease in gross profit is attributable to changes in the mix of service contracts.

### Research and Development

Research and development expense was $9.9 million in the three months ended September 30, 2010, an increase of $2.3 million, or 30.3%, compared with $7.6 million in the three months ended September 30, 2009. The increase was primarily due to increased payroll costs ($1.1 million), increased consulting costs ($0.9 million) and increased project material costs ($0.2 million). Research and development expense was $28.5 million for the nine months ended September 30, 2010, an increase of $3.6 million or 14.5%, compared with $24.9 million for the nine months ended September 30, 2009. The increase was comprised of increased payroll costs ($1.2 million), increased consulting costs ($1.5 million), increased project material costs ($0.8 million), and increased development asset amortization and depreciation costs ($0.1 million). Research and development expense was attributable to the following activities for the nine months ended September 30, 2010: 51% for new product development, 32% for improvement of existing products, and 17% for product testing.

### Sales and Marketing

In general the increase in sales and marketing expense is indicative of the improved market for our products. Sales and marketing expense was $7.2 million in the three months ended September 30, 2010, an increase of $1.5 million, or 26.3%, compared with $5.7 million for the three months ended September 30, 2009. The increase was primarily due to increased supplies and marketing service expenses of ($0.7 million), increased professional fee expenses ($0.3 million), increased travel costs ($0.3 million) and increased freight expenses ($0.3 million). Sales and marketing expense was $20.4 million for the nine months ended September 30, 2010, an increase of $1.5 million, or 7.9%, compared with $18.9 million for the nine months ended September 30, 2009. The increase was driven primarily by increased supplies and marketing service expenses ($0.8 million), increased travel costs ($0.8 million), increased freight expenses ($0.4 million), increased professional fees ($0.3 million), offset by decreased payroll costs ($0.3 million), decreased other miscellaneous expense ($0.3 million) and decreased taxes ($0.2 million).

### General and Administrative

General and administrative expense was $7.9 million for the three months ended September 30, 2010, equal to the spending in the three months ended September 30, 2009. General and administrative expense was $23.0 million for the nine months ended September 30, 2010, a decrease of $4.1 million, or 15.1%, compared with $27.1 million in the nine months ended September 30, 2009. The decrease was primarily due to decreased professional fee expenses ($5.0 million) and decreased other miscellaneous expense ($0.3 million), offset by increased payroll expense ($1.2 million).

### Restructuring

The company incurred no restructuring charges for the three and nine months ended September 30, 2010. During the three and nine months ended September 30, 2009, we implemented a reduction in force to further reduce costs to mitigate deteriorating industry fundamentals. This reduction in force resulted in a total charge to expense of approximately $6.1 million related to separation and outplacement costs for the nine months ended September 30, 2009, offset by a reversal of $0.6 million of accrued compensation expense related to terminated employees. A charge to expense of $0.4 million was recorded in the three months ended September 30, 2009.

### Other Income (Expense)

The sale of the Company’s investment in SEN resulted in a gain of approximately $1.1 million for the nine months ended September 30, 2009. This gain includes net proceeds of $122.2 million and cumulative foreign translation gain of $23.5 million, previously recorded in other comprehensive income, reduced by the carrying value of the investment on the date of sale of $144.6 million.

No equity loss or income was attributable to SEN for the three months ended September 30, 2009. Equity loss attributable to SEN was $3.2 million for the nine months ended September 30, 2009. As a result of the sale of the Company’s investment in SEN, subsequent to March 30, 2009, the Company no longer records equity income or loss from SEN.

We had no interest expense for the three and nine months ended September 30, 2010. Interest expense decreased by $1.7 million for the nine months ended September 30, 2010 compared to the nine months ended September 30, 2009. The decrease is due to the payment in full of the convertible senior subordinated notes on March 30, 2009. At September 30, 2010 the Company had no outstanding obligations incurring interest.

For the three and nine months ended September 30, 2010 the Company incurred $1.5 million and $0.9 million of non-cash foreign exchange losses compared to $1.0 million and $1.9 million for the comparable period of the prior year. For all periods presented, the primary reason for the non-cash charge was due to the weakening of the U.S dollar. Beginning in the fourth quarter of 2010 the Company instituted a hedging program to reduce the impact of currency fluctuations.

### Income Taxes

We incur income tax expense relating principally to operating results of foreign entities in jurisdictions, principally in Asia, where we earn taxable income. We have significant net operating loss carryforwards in the United States and certain foreign jurisdictions, principally Europe, and, as a result, we do not currently pay significant income taxes in those jurisdictions and we do not recognize the tax benefit for such losses as discussed in Note 9 to the consolidated financial statements. Accordingly, our effective income tax rate is not meaningful.

### Liquidity and Capital Resources

Our liquidity is affected by many factors. Some of these relate specifically to the operations of our business, for example, the rate of acceptance of the Optima product line, and others relate to the uncertainties of global economies, including the availability of credit, and the condition of the overall semiconductor equipment industry.

We have net operating loss and tax credit carryforwards which are available to reduce future income tax liabilities in the United States and certain foreign jurisdictions. These carryforwards, which expire principally between 2018 and 2028, had an aggregate tax effect of $90.2 million at December 31, 2009. The sale of our investment in SEN generated taxable income which we offset with existing net operating loss carry forwards.

During the nine months ended September 30, 2010, we experienced positive cash flows from operations. Cash and cash equivalents at September 30, 2010 were $49.1 million, compared to $45.0 million at December 31, 2009.

On March 12, 2010, we amended our existing revolving credit facility with a bank. The amended agreement provides for borrowings up to the lesser of $20 million or specified percentages of the amounts of qualifying accounts receivable and inventory. The facility has certain financial covenants requiring us to maintain minimum levels of operating results and liquidity. On May 25, 2010 the Company and its lender agreed to modify a financial covenant in the revolving credit facility regarding maximum allowable quarterly losses. Based on current forecasts, the Company believes it will be in compliance with the financial covenants, as modified, throughout 2010. We have not borrowed under this facility during 2010. The facility terminates on March 11, 2011. We do use the facility to support letters of credit and hedging transactions. We believe that based on our current market, revenue and expense forecasts, our existing cash and cash equivalents will be sufficient to satisfy our anticipated cash requirements for the foreseeable future. Our 2010 forecast reflects revenue and gross margins consistent with our understanding of customer plans, the improving market conditions currently forecasted by the industry (and experienced by the Company to date in 2010), and capacity utilization at customers’ manufacturing facilities. Forecasted operating expense levels are based on 2010 run rates.

### Recent Accounting Pronouncements

In September 2009, the FASB issued a new accounting standard to provide guidance on revenue recognition criteria for multiple-element arrangements. The new accounting standard modifies the criteria used to separate elements in a multiple-element arrangement by introducing the concept of best estimate of selling price, establishing a hierarchy of evidence for determining selling price (fair value), requiring the use of relative selling price method and prohibiting the use of the residual method to allocate arrangement consideration among units of accounting. The new accounting standard also expands the disclosure requirements for all multiple element arrangements and is effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010 (January 1, 2011 for a calendar year-end entity). The Company is currently evaluating the impact of adopting this pronouncement.

## Market risk

As filed, 191 characters.

As of September 30, 2010, there have been no material changes to the information about market risk disclosed in Item 7A to our annual report on Form 10-K for the year ended December 31, 2009.

## Controls and procedures

As filed, 1,021 characters.

### Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as of the end of the period covered by this report (the “Evaluation Date”). Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of the Evaluation Date, these disclosure controls and procedures are effective.

### Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during the third quarter of 2010 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 174 characters.

As of September 30, 2010, there have been no material changes to the risk factors described in Item 1A to our annual report on Form 10-K for the year ended December 31, 2009.

Filed Nov 5, 2010.
Source: SEC EDGAR, the filing index for accession 0001104659-10-056579. Last ingested by Listed: Nov 13, 2026, 17:24 ET. No prices; not investment advice.
